Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lanreotide Autogel vs Octreotide LAR in Acromegaly
NCT00145405Phase 4Completed
- Sponsor
- University Hospital Odense
- Start
- Sep 2002
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of lanreotide in acromegaly, sponsored by University Hospital Odense. Started Sep 2002; status: completed.
02
Drugs
lanreotide
03
Conditions
acromegaly
Beyond the preview
Go deeper on NCT00145405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00145405.